Infections Common Following Cellular Therapies for IMIDs
Summary
A systematic review finds substantial risks for infection and hypogammaglobulinemia, highlighting the need for better risk surveillance.
Description from Medscape.
Who is covering this
-
Infections Common Following Cellular Therapies for IMIDs
A systematic review finds substantial risks for infection and hypogammaglobulinemia, highlighting the need for better risk surveillance.
Comments
Comments need JavaScript.